{
    "Trade/Device Name(s)": [
        "VITROS XT Chemistry Products TBIL-ALKP Slides"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K190807",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CIG",
        "CJE"
    ],
    "Summary Letter Date": "March 28, 2019",
    "Summary Letter Received Date": "March 29, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1110"
    ],
    "Regulation Name(s)": [
        "Bilirubin (total or direct) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total bilirubin (TBIL)",
        "Alkaline phosphatase (ALKP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITROS XT 7600 Integrated Systems"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Slides"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS XT Chemistry Products TBIL-ALKP Slides for quantitative measurement of total bilirubin and alkaline phosphatase in serum and plasma.",
    "Indications for Use Summary": "Quantitative measurement of total bilirubin concentration and alkaline phosphatase activity in serum and plasma for diagnosis and treatment of liver, hematological, metabolic, bone, parathyroid, and intestinal diseases.",
    "fda_folder": "Clinical Chemistry"
}